Ovarian cancer accounts for more deaths than any other gynecologic cancer. In 2025, the World Health Organization estimates the disease ...
Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role ...
Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International win Asia's Best CEO from Corporate Governance Asia. Fosun ...
An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...
An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable ...
The trial is enrolling adult women with recurrent ovarian cancer after at least two previous therapies. Credit: Jo Panuwat D / Shutterstock.com. (Jo Panuwat D / Shutterstock.com.) Anixa Biosciences ...
Persistent disparities in preventive cancer care exist among sexual orientation and gender identity minority individuals in the United States, according to results of a cross-sectional analysis.The ...
At MSK, close to half of the surgeries just for colorectal cancer are done robotically, Dr. Garcia-Aguilar says. A leader in ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Morning Overview on MSN
The FDA cleared a breast cancer drug that added five months of survival for hard-to-treat tumors
Women diagnosed with advanced triple-negative breast cancer who cannot receive immunotherapy now have a new first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results